Recently, we reported endothelial dysfunction in GDM fetoplacental vessels characterized by reduced vasorelaxation in response to substance P. In addition, our recent study revealed a decrease in the mRNA expression of tachykinin receptor 1 (TACR1), the receptor for substance P [42]. The gene discussed is TACR1; the disease is gestational diabetes.